The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 08, 2020
Filed:
Nov. 02, 2018
Applicant:
Industrial Technology Research Institute, Hsinchu, TW;
Inventors:
Assignee:
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE, Hsinchu, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C08F 277/00 (2006.01); C08L 101/06 (2006.01); C08G 73/06 (2006.01); C08G 65/40 (2006.01); C08G 73/12 (2006.01); C08G 65/44 (2006.01); C08L 71/00 (2006.01); C08L 71/12 (2006.01); C07D 307/42 (2006.01); C07D 307/52 (2006.01); C07D 407/06 (2006.01); C08G 18/02 (2006.01); C08G 18/83 (2006.01); C08G 61/04 (2006.01); C08G 61/10 (2006.01); C08G 61/12 (2006.01); C08G 65/331 (2006.01); C08F 267/04 (2006.01); C08F 283/08 (2006.01); C08F 283/10 (2006.01); C08F 299/02 (2006.01);
U.S. Cl.
CPC ...
C08F 277/00 (2013.01); C07D 307/42 (2013.01); C07D 307/52 (2013.01); C07D 407/06 (2013.01); C08F 267/04 (2013.01); C08F 283/08 (2013.01); C08F 283/10 (2013.01); C08F 299/022 (2013.01); C08G 18/022 (2013.01); C08G 18/831 (2013.01); C08G 61/04 (2013.01); C08G 61/10 (2013.01); C08G 61/124 (2013.01); C08G 65/3318 (2013.01); C08G 65/40 (2013.01); C08G 65/44 (2013.01); C08G 73/0655 (2013.01); C08G 73/126 (2013.01); C08L 71/00 (2013.01); C08L 71/126 (2013.01); C08L 101/06 (2013.01); C08F 2500/02 (2013.01); C08F 2810/40 (2013.01); C08G 2261/149 (2013.01); C08G 2261/1646 (2013.01);
Abstract
A reversible crosslinking reactant composition is provided. The composition includes at least one furan-group-containing oligomer having a structure represented by Formula (I) and a bismaleimide compound having a structure represented by Formula (II), wherein the equivalent ratio of the furan group of the furan-group-containing oligomer having a structure represented by Formula (I) to the maleimide group of the bismaleimide compound having a structure represented by Formula (II) is from 0.5:1 to 1:0.5.